Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

729.29
-8.6927-1.18%
Number of Gainers:19
Number of Losers:31
Number of Flat:3
PE:- -
High:739.96
Open:738.04
Low:728.73
Close:737.98
Volume:70.04M
Turnover:1.00B
Market Cap:122.59B
Float Cap:76.60B

Loading ...

SY Holdings Grants New Share Options and Restricted Share Awards to Key Employees

TIPRANKS
·
Sep 28

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

THOMSON REUTERS
·
Sep 28

Immuneering Presents AACR Data Linking Atebimetinib Plus mGnP to Longer Survival in Pancreatic Cancer Study

Reuters
·
Sep 28

Aehr Test Systems CEO, CFO to Attend CEO Investor Summit

Reuters
·
Sep 28

Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)

TIPRANKS
·
Sep 28

RELX Expands Treasury Stock with Further Share Buybacks

TIPRANKS
·
Sep 28

Global Oil Prices Open Higher While Gold and Silver Fall Together

Deep News
·
Sep 28

Li Auto Weibo Lucky Draw Winner Announced: Luo Yonghao Wins iPhone 17 Pro Max, Netizens Joke They Thought It Was Photoshopped

Deep News
·
Sep 26

Mohawk is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Sep 25

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down for Week

MT Newswires Live
·
Sep 25

Li Auto Accused of Copying Volvo Ad as Volvo China Responds: Some Classics Are Remembered Each Time They Are Revisited

Deep News
·
Sep 25

Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas

Dow Jones
·
Sep 25

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)

TIPRANKS
·
Sep 25

3 Australian Hidden Gem Stocks With Up To 83% Fair Value Upside

Simply Wall St.
·
Sep 25

Ocugen Wins Provisional Approval for Ocu400 in Bahamas Under LARTA Pathway

Reuters
·
Sep 25

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in the Bahamas to Provide Ocu400 to Patients for Treatment of Retinitis Pigmentosa

THOMSON REUTERS
·
Sep 25

Bilibili Sets Record Dates Ahead of October 28 EGM on Off-Market Share Buy-Back

TIPRANKS
·
Sep 25

Bilibili Inc. to Hold Extraordinary General Meeting on October 28, 2026

GlobeNewswire
·
Sep 25

Here's How to Position Your Portfolio for the Next AI Wave, According to Morgan Stanley

Dow Jones
·
Sep 25

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

GlobeNewswire
·
Sep 25